| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 106 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 3,877 | $243.79 | $945,164.88 | -0.6% | +25.7% | +30.9% | |
| Feb 28, 2025 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 496 | $241.69 | $119,877.91 | -0.5% | +18.7% | +34.9% | |
| Feb 28, 2025 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sale+OE | 796 | $241.70 | $192,389.99 | -0.3% | +18.7% | +34.9% | |
| Feb 28, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sale+OE | 2,900 | $241.69 | $700,893.68 | -0.4% | +18.7% | +34.9% | |
| Feb 28, 2025 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sale+OE | 513 | $241.68 | $123,983.10 | -0.4% | +18.7% | +34.9% | |
| Feb 28, 2025 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sale+OE | 935 | $241.69 | $225,976.83 | -0.9% | +18.7% | +34.9% | |
| Feb 18, 2025 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 2,103 | $252.71 | $531,447.79 | -0.9% | +16.7% | +33.1% | |
| Feb 18, 2025 | Garg Pushkal50 | CMO &EVP Dev &Med Affairs | Sell | 3,109 | $253.43 | $787,904.15 | -1.3% | +16.7% | +33.1% | |
| Feb 14, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 1,213 | $255.17 | $309,526.58 | -0.1% | +10.5% | +22.6% | |
| Feb 14, 2025 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 967 | $255.17 | $246,749.79 | -0.2% | +10.5% | +22.6% |